Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urotensin-II-related peptide (Urotensin 2B, UTS2B, also known as URP) is a secreted peptide ligand, primarily expressed in the central nervous system and peripheral tissues, where it binds and activates the urotensin-II receptor, a G protein-coupled receptor involved in vasoconstriction, blood pressure regulation and neuroendocrine signaling. While closely related to urotensin-II, UTS2B is encoded by a distinct gene and has overlapping but not identical distribution and regulatory functions. Unlike the receptor (UT, GPR14), UTS2B itself is not a therapeutic target, but rather a ligand for the UT receptor, which is the pharmacological focus of drug development efforts[1][2][3].
Acts as an agonist at the Urotensin-II receptor (UT), activating Gq/11 and triggering intracellular calcium mobilization and protein kinase C pathways (for receptor, not the peptide)[1][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urotensin-II-related peptide (UTS2B).